30.08.2018
B.R.A.I.N. Biotechnology Research And Information Network AG DE0005203947
DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG: Natural-based Sweeteners - DOLCE core team announces membership changes in programme for natural-based sweeteners
DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG /
Key word(s): Miscellaneous
B.R.A.I.N. Biotechnology Research And Information Network AG: Natural-based
Sweeteners - DOLCE core team announces membership changes in programme for
natural-based sweeteners
30.08.2018 / 09:10
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Natural-based Sweeteners
DOLCE core team announces membership changes in programme for natural-based
sweeteners
* Business options for non-exclusive members were reshaped by the DOLCE
core team
* CPGC member who had access to the fields "morning foods" and "snacks"
left for company-internal strategic reasons
* DOLCE programme is moving forward and open for new partnerships
Zwingenberg, Potsdam (Germany)
La Madeleine Cedex (France)
August 30, 2018
The bioeconomy company BRAIN AG, the natural product specialist AnalytiCon
Discovery GmbH and Roquette, a global leader in specialty food ingredients
from plant-based raw materials - together the DOLCE core team - announce
today, that a CPGC member (Consumer Product Goods Company) of the DOLCE
partnership for natural-based sweetening solutions has left the program for
company-internal strategic reasons. The company was a partner to the
programme for the two food categories "morning foods" and "snacks".
New industry partners are invited to join DOLCE, allowing them to test the
natural-based sweetening solutions early in the development phase directly
within their specific product matrixes for their own product portfolio. For
non-exclusive members of the partnership the business model was reshaped to
enable the new members an easier access to the programme.
The goal of the DOLCE partnership is providing next generation natural-based
sweetening solutions for healthier food and beverages. Since the launch of
the programme in August 2016 significant product categories were selected.
The core team is currently preparing new partnerships for available product
categories and negotiations with potential members.
Sergio Neves, Head of Nutrition and Health R&D at Roquette Group, says:
"DOLCE is a great program. At the beginning of this year, we reached an
important milestone by identifying and characterizing a number of
natural-based sweet taste enhancers and high intensity sweeteners which we
can share with members of the partnership."
Martin Langer, EVP Corporate Development at BRAIN, says: "The DOLCE
programme is moving forward with high business potential for all parties
involved. We continue to invite further CPGCs to join our ongoing successful
programme."
Lutz Müller-Kuhrt, CEO of AnalytiCon Discovery states: "During the last two
years we made good progress in the programme. We started with 50 natural
sweetener candidates, now identified another 20, many of them new and
already applied for patent by the team. We are happy to provide this
collection of molecules to our DOLCE members and help them to reduce the
sugar load in their products."
For additional information on joining the DOLCE programme, please contact:
Dr. Martin Langer, BRAIN AG, Executive Vice President Corporate Development,
Tel.: +49-6251-9331-16, E-Mail: [email protected]
About BRAIN
B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG; ISIN
DE0005203947 / WKN 520394) is one of Europe's leading technology companies
in the field of industrial biotechnology, the core discipline of Bioeconomy.
As such, BRAIN identifies previously untapped, efficient enzymes, microbial
producer organisms or natural substances from complex biological systems
that can be put to industrial use. The innovative solutions and products
developed by help of this "Toolbox of Nature" are successfully applied in
the chemistry, the cosmetics and the food industries. BRAIN's business model
is based on two pillars - BioScience and BioIndustrial. The BioScience
comprises its frequently exclusive collaboration business with industrial
partners. BioIndustrial comprises the development and commercialization of
BRAIN's own products and active product components. Further information is
available at www.brain-biotech.de/en.
About AnalytiCon Discovery
AnalytiCon Discovery GmbH is a global market leader in the area of compound
libraries containing fully analyzed structures. Located on the Potsdam
Biotech Campus, the company offers services for every stage of the supply
chain for natural product-based (NP-based) substance discoveries and
developments. Innovative technology concepts enable high-grade partnerships
with globally operating companies from the pharmaceutical, food
manufacturing and cosmetics industries. AnalytiCon Discovery enjoys access
to around 15 percent of all natural compounds known worldwide, as well as to
thousands of structures that have not yet been published. AnalytiCon
Discovery has been a member of the BRAIN Group since 2013. Further
information is available at www.ac-discovery.com.
About Roquette: "Offering the best of Nature"
Roquette is a global leader in plant-based ingredients and a pioneer of new
vegetal proteins. In collaboration with its customers and partners, the
Group addresses current and future societal challenges by unlocking the
potential of Nature to offer the best ingredients for Food, Nutrition and
Health markets. Each of these ingredients responds to unique and essential
needs, and they enable healthier lifestyles. Thanks to a constant drive for
innovation and a long-term vision, the Group is committed to improving the
well-being of millions of people all over the world while taking care of
resources and territories. Roquette currently operates in over 100
countries, has a turnover of around 3.2 billion euros and employs 8,300
people worldwide. Further information is available at www.roquette.com.
BRAIN
Biotechnology Research
And Information Network AG
Darmstädter Str. 34-36
64673 Zwingenberg, Germany
www.brain-biotech.de
AnalytiCon Discovery GmbH
Hermannswerder Haus 17
14473 Potsdam, Germany
www.ac-discovery.com
Media Contact
Thomas Deichmann
Head of Public Relations
Tel.: +49-(0)-6251-9331-72
[email protected]
Corporate Develop. & IR Contact
Dr. Martin Langer
Executive Vice President
Corporate Development
Tel.: +49-(0)-6251-9331-16
Fax: +49-(0)-6251-9331-11
[email protected]
Roquette
101 avenue de la République
59564 La Madeleine Cedex
France
www.roquette.com
Media Contact
Carole Petitjean
Corporate Communications
Tel: +33 3 21 63 36 00
[email protected]
---------------------------------------------------------------------------
30.08.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: B.R.A.I.N. Biotechnology Research And Information Network
AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany
Phone: +49 (0) 62 51 / 9331-0
Fax: +49 (0) 62 51 / 9331-11
E-mail: [email protected]
Internet: www.brain-biotech.de
ISIN: DE0005203947
WKN: 520394
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
718179 30.08.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
B.R.A.I.N. Biotechnology Research And Information Network AG ISIN: DE0005203947 können Sie bei EQS abrufen
Biotechnologie , 520394 , BNN , XETR:BNN